Fred Hutch establishes scientific training program for high school and middle school teachers

Matteo Paz wins 2025 Regeneron Science Talent Search

Matteo Paz, 18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s longest-running and most distinguished science, technology, engineering, and math competition for high school seniors (The Cancer Letter, March 7, 2025).

March 14, 2025

Vol.51 No.10

In the Archives

Fred Hutch marks “50 years of doing hard things”

This year, Fred Hutch Cancer Center celebrates its 50th anniversary. Fred Hutch will be marking this milestone with a series of historical articles, a timeline, photo archives, and more as the year progresses.

March 07, 2025

Vol.51 No.09

In Brief

Fred Hutch announces 10 recipients of the annual Harold M. Weintraub Graduate Student Award

Fred Hutch Cancer Center announced 10 recipients of the annual Harold M. Weintraub Graduate Student Award, which recognizes the exceptional achievements of graduate studies in the biological sciences.

March 07, 2025

Vol.51 No.09

Clinical Roundup

New biomarker can predict cancer aggressiveness, study finds

Researchers from Fred Hutch Cancer Center and the University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers using a new technology and computational method.

February 21, 2025

Vol.51 No.07

Podcast

In The Headlines: Kimryn Rathmell on loss and caring for our community in uncertain times

In this episode of In the Headlines, former NCI Director Kimryn Rathmell speaks with Paul Goldberg, publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, about the HHS layoffs and their potential impact on mental health. These layoffs—and the broader uncertainty introduced by the current administration’s actions—are a form of trauma, Rathmell says.

February 19, 2025

Vol.51 No.06

Guest Editorial

Our challenge: To find zen in chaos

This column is a love letter of sorts to our field, a recognition of all that we have accomplished and an acknowledgement that we need to find a path forward that supports and empowers the best of what it is to invest in cancer research.

January 31, 2025

Vol.51 No.04

By W. Kimryn Rathmell